Supplementary Figure 4 from Baseline Biomarkers for Outcome of Melanoma Patients Treated with Pembrolizumab
Year: 2023
Type: supplementary-materials
Abstract: Alternative combination models according for the relative impact of LDH, REC, RLC and the pattern of visceral metastasis. A nomogram was developed using the nomogram function of R (A). For each patient a linear predictor score (risk score) considering the relative impact of four single factors was calculated as follows: LDH-ratio >2.5 - 100 points; presence of visceral metastasis other than lung - 96 points; REC <1.5% - 69 points; RLC <17.5% - 68 points. Thus, the resulting risk score (RS) ranges between 0 and 333 points. Kaplan-Meier analysis of overall survival is presented for 5 different combination models according to different risk score category definitions (B - E). Censoring is indicated by vertical lines. The discriminatory abilities (c-indices) for the respective models were 0.780 (B), 0.779 (C), 0.782 (D), 0.785 (E), and 0.781 (F).
Authors: Benjamin Weide, Alexander Martens, Jessica C. Hassel, Carola Berking, Michael A. Postow, Kees Bisschop, Ester Simeone, Johanna Mangana, Bastian Schilling, Anna Maria Di Giacomo, Nicole Brenner, Katharina Kähler, Lucie Heinzerling, Ralf Gutzmer, Armin Bender, Christoffer Gebhardt, Emanuela Romano, Friedegund Meier, Peter Martus, Michele Maio, Christian Blank, Dirk Schadendorf, Reinhard Dummer, Paolo A. Ascierto, Geke Hospers, Claus Garbe, Jedd D. Wolchok
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4361920700
